Half of Medicaid Patients With Diabetes, Heart Failure Do Not Get Follow-Up
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, June 8, 2023 -- More than half of Medicaid-covered adults with diabetes and heart failure in Alabama did not receive guideline-concordant postdischarge care, according to a study published online June 7 in the Journal of the American Heart Association.
Yulia Khodneva, M.D., from the University of Alabama at Birmingham, and colleagues examined postdischarge ambulatory care follow-up of patients with comorbid diabetes and heart failure from a low-income population in primary and specialty care. Analysis included 9,859 adults with diabetes and first hospitalizations for heart failure covered by Alabama Medicaid (2010 to 2019).
The researchers found that 26.7 percent had an ambulatory visit within seven days, 15.2 percent within eight to 14 days, 31.3 percent within 15 to 60 days, and 26.8 percent had no visit. Overall, 71 percent saw a primary care physician and 12 percent saw a cardiology physician. Any postdischarge ambulatory visits were less likely among Black and Hispanic/other adults. Furthermore, compared to non-Hispanic White patients, Black and Hispanic/other adults were more likely to have a delayed visit (by 1.8 days and by 2.8 days, respectively) and less likely to see a primary care physician (adjusted incidence rate ratios [95 percent confidence intervals], 0.96 [0.91 to 1.00] and 0.91 [0.89 to 0.98], respectively).
"Hopefully, this study will trigger additional, more in-depth studies that may help to explain the reasons for these observed racial disparities and help in the development of interventions to promote prompt follow-up for these patients," Khodneva said in a statement.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Semaglutide Reduces Need for Diuretics in Heart Failure
THURSDAY, May 16, 2024 -- Semaglutide reduces the need for loop diuretics and has positive effects on symptoms, physical limitations, and body weight in patients with heart...
Male, Female V1421 Carriers Face Similar Risk for Heart Failure Hospitalization
THURSDAY, May 16, 2024 -- Male and female V1421 carriers face a similar and substantial risk for heart failure hospitalization, according to a study published online May 12 in the...
Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure
FRIDAY, May 10, 2024 -- The Jarvik 2015 left ventricular assist device (LVAD) seems promising as an implantable continuous flow device for small children with severe systolic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.